세계의 아목시실린 시장 보고서(2025년)

Amoxicillin, a member of the penicillin group, is a broad-spectrum antibiotic used for treating a wide range of bacterial infections. Its mechanism involves inhibiting bacterial growth by preventing the formation of cell walls. This effectively combats infections including respiratory tract infections, urinary tract infections, skin infections, and certain types of bacterial endocarditis.

Amoxicillin belongs to the main drug classes of antibiotics such as penicillins, cephalosporins, tetracyclines, macrolides, and sulfonamides. Penicillins are derived from the Penicillium mold and share a core structure. The drug is available in various formulations including tablets, capsules, suspensions, syrup, and powder. It is used for treating infections such as skin infections, ear, nose, and throat infections, gastrointestinal infections, pulmonary infections, urinary tract infections (UTIs), pneumonia, bronchitis, and gonorrhea. These treatments are utilized across different settings including hospitals, homecare, specialty clinics, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The amoxicillin market research report is one of a series of new reports from The Business Research Company that provides amoxicillin market statistics, including amoxicillin industry global market size, regional shares, competitors with amoxicillin market share, detailed amoxicillin market segments, market trends and opportunities, and any further data you may need to thrive in the amoxicillin industry. This amoxicillin market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The amoxicillin market size has grown steadily in recent years. It will grow from $4.74 billion in 2024 to $4.9 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to an increased understanding of antibiotics, a higher pace of research activities and developments, increased cases of cardiovascular diseases, increased demand for amoxicillin in the treatment of urinary tract infections, rise in the aging population.

The amoxicillin market size is expected to see steady growth in the next few years. It will grow to $5.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.2%. The growth in the forecast period can be attributed to growing impaired renal function, prevalence of lower respiratory infections, increasing skin infections, growing cases of lower respiratory tract infections, and rising prevalence of bacterial infections. Major trends in the forecast period include demand for generic amoxicillin, focus on combination therapies, interest in probiotics and immunotherapy, demand for antibiotics, and advanced healthcare facilities.

The forecast of 3.2% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. market by increasing the cost of amoxicillin Active Pharmaceutical Ingredient(API) and finished dosage forms sourced from India and China, thereby reducing antibiotic accessibility and elevating primary care prescription expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The rising prevalence of infectious diseases is anticipated to drive the growth of the amoxicillin market in the coming years. Infectious diseases, caused by pathogenic microorganisms such as bacteria, viruses, fungi, or parasites, are becoming more common due to factors such as global travel, antimicrobial resistance, climate change affecting disease vectors, and higher population density. Amoxicillin is effective in treating these diseases by targeting bacterial cell wall synthesis, leading to bacterial cell death. Its broad-spectrum activity, rapid absorption, and ability to work synergistically with other antibiotics make it a versatile and effective treatment for various bacterial infections. For example, in January 2023, the National Institute of Health reported that urinary tract infections ranked seventh among the leading reasons for emergency department visits in the US, accounting for over 1 million visits annually. Of these, 22% (220,000) were classified as complicated UTIs, with approximately 100,000 cases resulting in hospital admissions each year. Consequently, the increasing prevalence of infectious diseases is fueling the growth of the amoxicillin market.

The increase in healthcare expenditure is expected to drive the growth of the amoxicillin market in the future. Healthcare expenditure refers to the total money spent on healthcare goods and services, including medical treatments, medications, hospitalizations, and preventive care, within a specific period. This expenditure reflects the overall cost of healthcare provision within a population. The rising healthcare expenditures are due to the increasing costs of advanced medical technologies, aging populations, and the prevalence of chronic diseases. Increased healthcare expenditure benefits amoxicillin by ensuring wider accessibility and availability, leading to higher prescription rates and improved patient outcomes. Enhanced funding also supports research and development, potentially leading to better formulations and broader usage of the antibiotic. For example, in January 2024, the National Institutes of Health reported that healthcare expenditure in the US rose by 4.1% in 2022 to reach $4.5 trillion, marking a faster growth rate compared to the 3.2% increase observed in 2021. Thus, the increase in healthcare expenditure is driving the growth of the amoxicillin market.

Major companies in the amoxicillin market are developing innovative drugs, such as reformulated versions of vonoprazan tablets, to enhance the treatment of Helicobacter pylori infections and improve patient outcomes. Vonoprazan is a novel potassium-competitive acid blocker (PCAB), a new class of acid suppressant medication. For example, in May 2022, Phathom Pharmaceuticals, a US-based pharmaceutical company, received U.S. Food and Drug Administration (FDA) approval for VOQUEZNA TRIPLE PAK (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA DUAL PAK (vonoprazan, amoxicillin) for the treatment of Helicobacter pylori (H. pylori) infection in adults. These treatment regimens include antibiotics conveniently packaged with vonoprazan, a novel potassium-competitive acid blocker (PCAB), marking the first innovative acid suppressant from a new drug class approved in the U.S. in over 30 years.

Major companies operating in the amoxicillin market are Pfizer Inc., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline Plc, Merck KGaA, Teva Pharmaceutical Industries Ltd., Alkem Laboratories Ltd., Sun Pharmaceutical Industries Ltd., CSPC Pharmaceutical Group Limited, Torrent Pharmaceuticals GmbH, Aurobindo Pharma Limited, Hikma Pharmaceuticals PLC, Intas Pharmaceuticals Ltd., Lupin Limited, Daewoong Pharmaceutical Co. Ltd., Centrient Pharmaceuticals, Wockhardt Limited, Ranbaxy Laboratories Ltd., Atman Pharmaceuticals, Sinopharm Weiqida Pharmaceutical Co. Ltd., Cipla Inc., Zydus Cadila

North America was the largest region in the amoxicillin market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the amoxicillin market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the amoxicillin market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The amoxicillin market consists of sales of oral formulations, liquid formulations, extended-release tablets, and specialty products. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Amoxicillin Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on amoxicillin market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for amoxicillin ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The amoxicillin market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Drug Class: Penicillin; Cephalosporin; Tetracycline; Macrolides; Sulfonamides
• 2) By Therapy Type: Monotherapy; Combinational Therapy
• 3) By Form: Tablets; Capsule; Suspensions; Syrup; Powder
• 4) By Infection Type: Skin Infections; Ear, Nose And Throat Infections; Stomach Infections; Lungs Infections; Urinary tract infections (UTI); Pneumonia; Bronchitis; Gonorrhea
• 5) By End User: Hospitals; Homecare; Specialty Clinics; Other End Users
• Subsegments:
• 1) By Penicillin: Penicillin G; Penicillin V; Extended-Spectrum Penicillins (Amoxicillin); Beta-Lactam Antibiotics
• 2) By Cephalosporin: First-Generation Cephalosporins (Cephalexin); Second-Generation Cephalosporins (Cefuroxime); Third-Generation Cephalosporins (Ceftriaxone); Fourth-Generation Cephalosporins (Cefepime)
• 3) By Tetracycline: Doxycycline; Minocycline; Tetracycline Hydrochloride
• 4) By Macrolides: Azithromycin; Erythromycin; Clarithromycin
• 5) By Sulfonamides: Sulfamethoxazole; Sulfadiazine; Sulfasalazine; Trimethoprim-Sulfamethoxazole Combination
• Companies Mentioned: Pfizer Inc.; Sanofi S.A.; AstraZeneca Plc; Novartis AG; GlaxoSmithKline Plc; Merck KGaA; Teva Pharmaceutical Industries Ltd.; Alkem Laboratories Ltd.; Sun Pharmaceutical Industries Ltd.; CSPC Pharmaceutical Group Limited; Torrent Pharmaceuticals GmbH; Aurobindo Pharma Limited; Hikma Pharmaceuticals PLC; Intas Pharmaceuticals Ltd.; Lupin Limited; Daewoong Pharmaceutical Co. Ltd.; Centrient Pharmaceuticals; Wockhardt Limited; Ranbaxy Laboratories Ltd.; Atman Pharmaceuticals; Sinopharm Weiqida Pharmaceutical Co. Ltd.; Cipla Inc.; Zydus Cadila
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Amoxicillin Market Characteristics

3. Amoxicillin Market Trends And Strategies

4. Amoxicillin Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Amoxicillin Growth Analysis And Strategic Analysis Framework

• 5.1. Global Amoxicillin PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Amoxicillin Market Growth Rate Analysis
• 5.4. Global Amoxicillin Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Amoxicillin Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Amoxicillin Total Addressable Market (TAM)

6. Amoxicillin Market Segmentation

• 6.1. Global Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin
• Cephalosporin
• Tetracycline
• Macrolides
• Sulfonamides
• 6.2. Global Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Monotherapy
• Combinational Therapy
• 6.3. Global Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tablets
• Capsule
• Suspensions
• Syrup
• Powder
• 6.4. Global Amoxicillin Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Skin Infections
• Ear, Nose And Throat Infections
• Stomach Infections
• Lungs Infections
• Urinary tract infections (UTI)
• Pneumonia
• Bronchitis
• Gonorrhea
• 6.5. Global Amoxicillin Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Homecare
• Specialty Clinics
• Other End Users
• 6.6. Global Amoxicillin Market, Sub-Segmentation Of Penicillin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Penicillin G
• Penicillin V
• Extended-Spectrum Penicillins (Amoxicillin)
• Beta-Lactam Antibiotics
• 6.7. Global Amoxicillin Market, Sub-Segmentation Of Cephalosporin, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• First-Generation Cephalosporins (Cephalexin)
• Second-Generation Cephalosporins (Cefuroxime)
• Third-Generation Cephalosporins (Ceftriaxone)
• Fourth-Generation Cephalosporins (Cefepime)
• 6.8. Global Amoxicillin Market, Sub-Segmentation Of Tetracycline, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Doxycycline
• Minocycline
• Tetracycline Hydrochloride
• 6.9. Global Amoxicillin Market, Sub-Segmentation Of Macrolides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Azithromycin
• Erythromycin
• Clarithromycin
• 6.10. Global Amoxicillin Market, Sub-Segmentation Of Sulfonamides, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sulfamethoxazole
• Sulfadiazine
• Sulfasalazine
• Trimethoprim-Sulfamethoxazole Combination

7. Amoxicillin Market Regional And Country Analysis

• 7.1. Global Amoxicillin Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Amoxicillin Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Amoxicillin Market

• 8.1. Asia-Pacific Amoxicillin Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Amoxicillin Market

• 9.1. China Amoxicillin Market Overview
• 9.2. China Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Amoxicillin Market

• 10.1. India Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Amoxicillin Market

• 11.1. Japan Amoxicillin Market Overview
• 11.2. Japan Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Amoxicillin Market

• 12.1. Australia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Amoxicillin Market

• 13.1. Indonesia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Amoxicillin Market

• 14.1. South Korea Amoxicillin Market Overview
• 14.2. South Korea Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Amoxicillin Market

• 15.1. Western Europe Amoxicillin Market Overview
• 15.2. Western Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Amoxicillin Market

• 16.1. UK Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Amoxicillin Market

• 17.1. Germany Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Amoxicillin Market

• 18.1. France Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Amoxicillin Market

• 19.1. Italy Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Amoxicillin Market

• 20.1. Spain Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Amoxicillin Market

• 21.1. Eastern Europe Amoxicillin Market Overview
• 21.2. Eastern Europe Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Amoxicillin Market

• 22.1. Russia Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Amoxicillin Market

• 23.1. North America Amoxicillin Market Overview
• 23.2. North America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Amoxicillin Market

• 24.1. USA Amoxicillin Market Overview
• 24.2. USA Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Amoxicillin Market

• 25.1. Canada Amoxicillin Market Overview
• 25.2. Canada Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Amoxicillin Market

• 26.1. South America Amoxicillin Market Overview
• 26.2. South America Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Amoxicillin Market

• 27.1. Brazil Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Amoxicillin Market

• 28.1. Middle East Amoxicillin Market Overview
• 28.2. Middle East Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Amoxicillin Market

• 29.1. Africa Amoxicillin Market Overview
• 29.2. Africa Amoxicillin Market, Segmentation By Drug Class, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Amoxicillin Market, Segmentation By Therapy Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Amoxicillin Market, Segmentation By Form, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Amoxicillin Market Competitive Landscape And Company Profiles

• 30.1. Amoxicillin Market Competitive Landscape
• 30.2. Amoxicillin Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Sanofi S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca Plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Novartis AG Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. GlaxoSmithKline Plc Overview, Products and Services, Strategy and Financial Analysis

31. Amoxicillin Market Other Major And Innovative Companies

• 31.1. Merck KGaA
• 31.2. Teva Pharmaceutical Industries Ltd.
• 31.3. Alkem Laboratories Ltd.
• 31.4. Sun Pharmaceutical Industries Ltd.
• 31.5. CSPC Pharmaceutical Group Limited
• 31.6. Torrent Pharmaceuticals GmbH
• 31.7. Aurobindo Pharma Limited
• 31.8. Hikma Pharmaceuticals PLC
• 31.9. Intas Pharmaceuticals Ltd.
• 31.10. Lupin Limited
• 31.11. Daewoong Pharmaceutical Co. Ltd.
• 31.12. Centrient Pharmaceuticals
• 31.13. Wockhardt Limited
• 31.14. Ranbaxy Laboratories Ltd.
• 31.15. Atman Pharmaceuticals

32. Global Amoxicillin Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Amoxicillin Market

34. Recent Developments In The Amoxicillin Market

35. Amoxicillin Market High Potential Countries, Segments and Strategies

• 35.1 Amoxicillin Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Amoxicillin Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Amoxicillin Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer